» Articles » PMID: 3753996

Modulation of Endothelial Cell Hemostatic Properties by Tumor Necrosis Factor

Overview
Journal J Exp Med
Date 1986 Mar 1
PMID 3753996
Citations 261
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor/cachectin (TNF) is a mediator of the septic state, which involves diffuse abnormalities of coagulation throughout the vasculature. Since previous studies have shown that endothelial cells can play an active role in coagulation, we wished to determine whether TNF could modulate endothelial cell hemostatic properties. Incubation of purified recombinant TNF with cultured endothelial cells resulted in a time- and dose-dependent acquisition of tissue factor procoagulant activity. Concomitant with enhanced procoagulant activity, TNF also suppressed endothelial cell cofactor activity for the anticoagulant protein C pathway; both thrombin-mediated protein C activation and formation of functional activated protein C-protein S complex on the cell surface were considerably attenuated. Comparable concentrations of TNF (half-maximal affect at approximately 50 pM) and incubation times (half-maximal affect by 4 h after addition to cultures) were required for each of these changes in endothelial cell coagulant properties. This unidirectional shift in cell surface hemostatic properties favoring promotion of clot formation indicates that, in addition to leukocyte procoagulants, endothelium can potentially be instrumental in the pathogenesis of the thrombotic state associated with inflammatory and malignant disorders.

Citing Articles

Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence.

Subramaniam S, Jose A, Kenney D, OConnell A, Bosmann M, Douam F Front Immunol. 2025; 16:1443932.

PMID: 39967675 PMC: 11832389. DOI: 10.3389/fimmu.2025.1443932.


Immunity and Coagulation in COVID-19.

Avdonin P, Blinova M, Serkova A, Komleva L, Avdonin P Int J Mol Sci. 2024; 25(20).

PMID: 39457048 PMC: 11508857. DOI: 10.3390/ijms252011267.


Interferons prime the endothelium for toll-like receptor-mediated thrombin generation.

Sack K, Eaton N, Doroudian Tehrani M, Flaumenhaft R J Thromb Haemost. 2023; 22(4):1215-1222.

PMID: 38159649 PMC: 10960681. DOI: 10.1016/j.jtha.2023.12.021.


Endothelial Glycocalyx Injury in SARS-CoV-2 Infection: Molecular Mechanisms and Potential Targeted Therapy.

Lv B, Huang S, Huang H, Niu N, Liu J Mediators Inflamm. 2023; 2023:6685251.

PMID: 37674786 PMC: 10480029. DOI: 10.1155/2023/6685251.


Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism.

Dai W, Castleberry M, Zheng Z J Thromb Haemost. 2023; 21(10):2679-2696.

PMID: 37579878 PMC: 10599797. DOI: 10.1016/j.jtha.2023.08.004.


References
1.
Nawroth P, STERN D, Kisiel W, Bach R . Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res. 1985; 40(5):677-91. DOI: 10.1016/0049-3848(85)90305-6. View

2.
Gordon S, CROSS B . A factor X-activating cysteine protease from malignant tissue. J Clin Invest. 1981; 67(6):1665-71. PMC: 370742. DOI: 10.1172/jci110203. View

3.
Bach R, Nemerson Y, Konigsberg W . Purification and characterization of bovine tissue factor. J Biol Chem. 1981; 256(16):8324-31. View

4.
Rosenberg R, Rosenberg J . Natural anticoagulant mechanisms. J Clin Invest. 1984; 74(1):1-6. PMC: 425178. DOI: 10.1172/JCI111389. View

5.
Bevilacqua M, Pober J, Majeau G, COTRAN R, Gimbrone Jr M . Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160(2):618-23. PMC: 2187463. DOI: 10.1084/jem.160.2.618. View